Company Profile
Vivos Therapeutics Stock Price, News & Catalysts
- Ticker:
- VVOS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.30 USD (-12.26%)
Close
Last updated: August 17, 2026
9.42M USD
Market cap
Why the stock is moving
Following the latest company update, “Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update”, VVOS closed down 12.3% at $0.3012 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Sleep-Related Breathing Disorder Platform
Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders. Its approach combines proprietary oral appliances with diagnostic and clinical services intended to address the anatomical contributors to impaired nighttime breathing.
CARE Oral Appliances
The company's Complete Airway Repositioning and Expansion, or CARE, devices are designed to modify the oral and craniofacial structures associated with airway obstruction. The portfolio includes FDA-cleared appliances for adults across the spectrum of obstructive sleep apnea severity, including severe disease.
Pediatric and Adult Indications
Vivos has expanded its regulatory footprint beyond adult treatment. Its DNA appliance is FDA-cleared for moderate-to-severe obstructive sleep apnea in children ages six through 17, giving the company a platform spanning both pediatric and adult populations.
Integrated Diagnostic and Treatment Services
In addition to device sales, Vivos operates Sleep and Airway Medicine Centers and Sleep Center of Nevada. These businesses provide sleep testing, physician-directed treatment, and related services, creating an integrated model that connects diagnosis with oral-appliance and broader sleep-care delivery.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vivos Therapeutics (VVOS)?
Vivos Therapeutics (VVOS) most recently closed at 0.30 USD, a -12.26% move versus the previous session.
What is the market cap of Vivos Therapeutics (VVOS)?
Vivos Therapeutics currently has a market capitalization of 9.42M USD on BioPharmSignal.
What does Vivos Therapeutics do?
Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders. Its approach combines proprietary oral appliances with diagnostic and clinical services intended to address the anatomical contributors to impaired nighttime breathing. CARE...
On which exchange is VVOS stock listed?
Vivos Therapeutics (VVOS) is associated with NASDAQ, United States, Biopharma.
What is Sleep-Related?
Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders.
Which conditions is Vivos Therapeutics targeting with Sleep-Related?
Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders. Its approach combines proprietary oral appliances with diagnostic and clinical services intended to address the anatomical contributors to impaired nighttime breathing. CARE...
What is Breathing?
Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders.
What is Disorder?
Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders.